Roth MKM Sticks to Their Buy Rating for OS Therapies Incorporated (OSTX)
at www.tipranks.com (Wed, 18-Nov 11:15 AM)
Market Chameleon (Tue, 6-Oct 10:28 AM)
OSTX Gains FDA Alignment on Phase 3 Adaptive Design as MHRA Leads Project Orbis for OST-HER2
Market Chameleon (Thu, 17-Sep 10:26 AM)